Galectin Therapeutics Inc. (NASDAQ:GALT) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for fibrotic disease, cancer,…
Galectin Therapeutics Inc. (NASDAQ:GALT) is a clinical-stage biotechnology company headquartered in Norcross, Georgia, pioneering the development of novel…